CClinicalTrials.gg
RecruitingNCT03798158DyHPUpdated Jul 23, 2021

Prevalence and Characterization of Persistent Dyspnea After Hospitalization

An observational study in Dyspnea and Pulmonary Disease, sponsored by Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-07-23.

Sponsored by Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Study summary

The investigators aim to make an overview of persistent dyspnea at the end of an hospitalization for a respiratory disease using an actual tool, the Multidisciplinary Dyspnea Profile questionnaire.

02

Conditions studied

  • Dyspnea
  • Pulmonary Disease

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Every consecutive patient admitted to hospitalization for a respiratory cause having a significant dyspnea

Inclusion criteria

  • Age over 18 years old
  • Able to respond the questionnaire
  • Presenting at admission a dyspnea over 3/10 on numerical analogic scale
  • Admitted for a respiratory cause

Exclusion criteria

Exclusion Criteria:

  • cognitive impairment
  • aphasia
  • no french-speaking person
04

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Interventions

  • OtherMultidisciplinary Dyspnea Profile questionnaire

    Multidisciplinary Dyspnea Profile questionnaire at the beginning and the end of an hospitalization

05

What researchers measure

Primary outcomes

  1. Prevalence of persistent dyspnea in the end of an hospitalization for a a respiratory disease

    Time frame: An average of one week, until the end of the hospitalization

Secondary outcomes

  1. Characterization of persistent dyspnea using MDP

    Time frame: An average of one week, until the end of the hospitalization

  2. Outcome of patients with persistent dyspnea after hospitalization

    6 months mortality, incidence of rehospitalization

    Time frame: 6 months

06

Study locations

1 of 1 sites recruiting
07

Registry details

Key details

Study ID
NCT03798158
Lead sponsor
Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
Responsible party
Sponsor
First posted
Jan 9, 2019
Start date
Apr 11, 2019
Primary completion
Apr 30, 2025 (estimated)
Completion
Apr 30, 2025 (estimated)
Last update
Jul 23, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion